OpenLoop is infrastructure, not a consumer GLP-1 comparison entry. Its website says brands can launch programs under their own names while OpenLoop supplies technology and operations behind the scenes.
At the September 10, 2026 review, the company reported more than 2,000 clinicians across all 50 states and 35-plus specialties, support for medical weight loss, and integrations covering patient intake, portals, communications, clinical workflows, pharmacy, and diagnostics. Those are company-reported figures and have not been independently audited by GLP.directory.
This report is general information, not medical advice. A licensed clinician who knows your history should guide treatment, prescribing, dosing, and switching decisions. Compounded drugs are not FDA approved.